Anglo Asian Mining Share Discussion Threads

[baddeal] 14/6/2020 12:33

Don't have a day job DD, I managed to retire early after making some good investments, think how richer I'd be if I relied on your picks. Perhaps I could become a client?You haven't yet answered by last q re the hardman report where you pointed out the folly in their ways of valuing the company on dcf. I did ask how you would recommend we humble pi's do value aaz. Clearly you're in the know on mining shares as you keep pointing out to us there are better alternatives. I await your response and an interesting Sunday afternoon read....

[jbravo2] 14/6/2020 12:29

He won’t ever stick his neck out and name a tip.
He’s afraid it’ll be as bad a call as his last sell rec on here.
The one that saw “his clients” miss out on a 40% rise.
He’ll need to start using another I.D. soon. Good job he’s got plenty.

[donnatella] 14/6/2020 12:20

Pretty sure dozy stated on here he was advising his 'clients' to buy HUM.
Incidentally another dozey on that board :)

[jbravo2] 14/6/2020 11:42

His clients rely on his honesty and integrity ;D
Hence his need for multiple I.D.s

[spidertricks] 14/6/2020 11:16

His clients are probably of the ilk of Keith Vaz

[qazwsxedc69] 14/6/2020 11:13

Meanwhile we look forward to hearing all about your incredible alternatives that I'm sure your 'clients' (ahem) pay you good money for tipping them about.......

[qazwsxedc69] 14/6/2020 11:09

Dozy, dozy, dozy.Is that the best you can do? Honestly? You clearly have a chip on your shoulder and your ego is hurt. So you are lashing out. I understand. And yet this is the best you can do? You must try harder. Your flimsy non-existent 'arguments' just serve to show just how good the investment case is here.......

[wanobi] 14/6/2020 11:04

many thanx all, cheers Wan :-)

[riggerbeautz] 14/6/2020 11:02

Some might laugh but another gut product is collidal silver, can be good for skin conditions and I’ve had it to clear colds; I’ll swear it makes a difference, the medical profession dismiss it....me thinks hmm wonder why? Each to their own, but it cured skin rash I had when playing sport and I swear small doses cure colds etc. Just have to not get too addicted, known to change skin tone! You have to google that to see.

[goodgrief] 14/6/2020 11:00

Well, just as well we've got Steven Whitehead proving up the exploration. 1 year into a 3 year exploration plan, hope they publish something interesting over the coming weeks.

[11_percent] 14/6/2020 11:00

Ref post 509, from the article......says it all.


What does it tell you about our present financial system when one can earn over 10% lending one’s gold bullion but be asked to pay interest to deposit Euros or Swiss Francs?

[c0lin1] 14/6/2020 10:59

answer his question about what stocks he should be buying

[riggerbeautz] 14/6/2020 10:58

Morning Wan, admire your enthusiasm for looking at recovery plays, I’d be looking for ones that might benefit in a new type of economy, with online sales etc. Bit like I mentioned WEY; if they can’t ramp up now, when will they, plus they are a sector tiddler, so always chance of a predator.

The AA. was more what I’d call a special situation, someone selling down heavy drags the price down regardless of balance sheet, profitability and prospects. When I feel those situations are skewing a share I take note as you often see a reversal once the seller moves on. It’s what got me into Mavinwood which then became Restore years ago and it’s what attracted me to AAZ when Bashirov was selling, in both cases I waited until I thought the seller was about out or gone.

The AA. I’m less certain as global woes can drag it back, but this week should see a fair idea of what’s in store. Whitbread I guess is similar to MARS but I only jumped on that because of the Carlsberg deal, it just seemed an obvious value disconnect to me, so unless Whitbread has something going on in the background, I’ll not pay much attention.

[pogue] 14/6/2020 10:51

Am I the only one looking at selling down holdings for fear of the major crash part 2?
My plan currently is to sell off everything apart from gold miners and AIM pharmas, even those I will be pruning some of the under performers, I am very concerned about the fact the many companies are hoarding cash and cutting workforce, they are not preparing for good times or a sudden bounce back of epic proportions as the markets seem to imply.
Was Zoom drinking with an old buddy last night who works in a large multinational company which is talking internally of 40% staff cuts to be announced soon, that is worrying as it’s a picks and shovels type company which normally plods on through everything.
I took Thursday’s correction as a warning shot and sold out completely on 3 positions I was at par or better in, will start selling more next week, am I mad?

[dozyduck] 14/6/2020 10:51

A close read of Hardmans report shows it is practically all speculation (and padding to justify their eye-watering fee) re extending Gedabek, and especially Ordubad where AAZ doesn't even know what style system it is (or whether gold/copper as opposed to zinc etc) let alone its possible size or whether economic to develop. That's why MF's 'speculation' shows total pig-ignorance and 'misses' everything I've listed. So I'll keep pointing out to the other porcine posters jb and skept the facts that any mining analyst or investor will have worked out already - which is there are too many unknowns affecting AAZ's medium term future to recommend investing in it now, and to move to better prospects elsewhere.

[skeptic1] 14/6/2020 10:32

He’s back! Wahoo! Not sure I’d trust him Jbravo - even when looking at things that have already happened, he still finds it impossible to make the right calls. Shame really. Just ignore and move on like most have 😂

[the stigologist] 14/6/2020 10:08

Speaking of Companies who've already got the Placings out of the way...

I have taken the time to annotate Physiomics PYC recent RNS regarding a Fundraise (27th May 2020). My notes are in blue text

The fundraise level was at 3.5p but the shares closed this week close to 5p which represents, I believe, evidence of a well executed Fundraise because it seems there was little retail/bucket shop involvement and any Institutions partaking seem to be buying in the secondary market providing a strong underlying bid to the stock.

Company : Physiomics
Ticker : PYC
Share Price : 4.70p
Shares o/s : 95.6m
Market Cap : £4.5m
Cash : £1.2m (comprising £0.4m at y/e 2019 + Placing proceeds of £0.8m)
Revenue (CY 2019) : £0.8m
Price/Revenue : 5.5x



Physiomics completes £0.83m (gross) fundraise to fund growth opportunities

Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens and personalised medicine solutions, is pleased to announce that it has completed a placing and subscription, conditional on Admission, to raise approximately £828,750 (gross) from the issue of 23,678,571 new ordinary shares of 0.4p each ("Ordinary Shares") at an issue price of 3.5p per share, through Hybridan LLP (the "Fundraise").

In the last few years, the Company has made significant progress, including:

• 70% compounded annual growth in total income FY 2017- 2019, culminating in its highest ever total income in FY 2019 of £783k

• >£1m of contracts announced with Merck KGaA since master services agreement announced in November 2017

• Significant new clients CellCentric Ltd (Apr 2018) and Bicycle Therapeutics plc (June 2019) added and repeat contracts signed with both

• Completion of a second Innovate UK grant project focused on personalised treatment of advanced prostate cancer (May 2019) and subsequent presentation of results at NIHR event at Royal Marsden Hospital

• Award of NIHR i4i grant (March 2020) to undertake an observational trial to generate data in support of personalised dosing tool in advanced prostate cancer

• Entering into discussions with companies with an established presence in the field of personalised medicine with a view to exploring how its technology could be commercialised

[NOTE : Of the 6 bullet points 3 are related to Personalised Medicine. Physiomics comparitors in its core M&S business are valued at 15-30x Revenue ! BUT Companies in the Personalised Medicine AI/ML space can be valued at HUNDREDS of Millions e.g. Google took over Deepmind for $500m in 2014 ; Benevolent AI is a £1bn+ Unicorn)]

On 3 March 2020, the Company announced, as part of its unaudited interim results statement, that it held cash and cash equivalents of £434k as at 31 December 2019 and that it had achieved a small positive cash inflow for the six months ended on the same date. On 19 March 2020, the Company further confirmed that it had a strong pipeline of work and the Directors believe that this has been further strengthened since that announcement.

[NOTE : Physiomics already had CASH and was CASHFLOW positive so why raise money ? In my experience when Companies with enough cash raise money it's because a Large Potential Customer is considering a large contract and they want to be sure that the much smaller player will be around to service them in ANY CIRCUMSTANCES so require evidence of a significantly stronger Balance Sheet... and guess what...]

In this regard, in the last two working days, the Company has received a strong indication that a significant contract is likely to be signed with a new large pharmaceutical client, with which it has been in discussions since late 2019. While is it still possible that the potential new client could withdraw, it is the Directors' opinion that this is unlikely. Should the contract be signed, the work is expected to take two of our technical staff around five months to complete.

[NOTE : Physiomics main employees all have backgrounds with GSK and AZN which could point to the 'Large Pharma' being one of those ? There are c.50 Large Pharmas worldwide and outsourcing of specialist but non-core functions like Modelling & Simulation is a big growth industry so even if it isn't GSK or AZN this time, I would expect them to get involved later. One of the major advantages of PYC tech is ability to model combination treatments. Interesting in this regard that PYC's existing Big Pharma customer Merck has major collaborations with Big Pharma like GSK and Pfizer combining treatments in the exact Immuno-oncology space Physiomics software plays into]

In order to further develop its business, the Company is raising funds through the Fundraise to enable it to carry out activities including increasing its sales & marketing spend, recruiting a further member of its technical team and further investing in its personalised medicine technology as well as for general working capital purposes.

Director Participation in the Fundraise

Dr Jim Millen (CEO), Dr Paul Harper (Chairman) and Dr Christophe Chassagnole (COO) have participated in the Fundraise in the amounts of £3,000, £5,000 and £3,000 respectively (the "Directors' Participation") and will be issued 85,715 Ordinary Shares, 142,857 Ordinary Shares and 85,715 Ordinary Shares respectively. On Admission, Dr Millen, Dr Harper and Dr Chassagnole will be interested in, in aggregate, 530,356, 668,564 and 602,723 Ordinary Shares respectively, representing 0.55%, 0.70% and 0.63%, of the Company's then enlarged issued share capital.

[NOTE : This is the first time I can recall that ALL Physiomics Directors participated with their own money in a Placing. Some have made derogatory comments about the 'size' of the involvement. Fact of the matter is many People do not have a lot of spare cash to throw at Investments, one would imagine Directors already have exposure to PYC they should if anything diversify not concentrate exposure, however Management collectively own Shares and Options exceeding 6% of the Company so they are well incentivised and aligned with shareholders]

Dr Jim Millen, CEO said: "We are delighted by the response to this over-subscribed fundraise. We thank our current shareholders for their continued support and have achieved another milestone by welcoming our first small-cap institutional fund onto the register. We believe this is reflective of our strong commercial traction over the last four years.

Our team is committed to continuing to support global pharma and biotech companies in their drug discovery and development endeavours, and these funds will be mainly focused on growing our already strong pipeline of new business opportunities. I look forward to continuing to update shareholders on our progress."

[callmebwana] 14/6/2020 10:06

Good morning Wan. Not RB but me.
When are the pubs going to open Wan ?
I can only guess at that Wan when there is a cure for CV-19.
Have a good day all.
ATB.

[the stigologist] 14/6/2020 10:05

I think the problem with many of these Consumer focused Companies is that they are very economically sensitive. The economy is not coming back in a V shaped manner (unlike the Stock Market) so they will suffer from uncertainty for quite a while. Bad CEOs can also 'get out of jail' by blaming covid for everything. I'd watch out for kitchen-sinking trading statements and placings to shore up balance sheets. City bankers need to pay their kids school fees so will be advising Companies to do placings to take advantage of retail euphoria/Fed largesse.

[wanobi] 14/6/2020 09:37

In my quest for recovery plays I came across this most obvious one,,, which seems to have not recovered much at all so far,,, any thoughts Rb, cheers Wan :-)


free stock charts from uk.advfn.com

[wanobi] 14/6/2020 09:36

Good Morning all, good luck and good health to you all :-) Cheers Wan :-)

[jbravo2] 14/6/2020 09:23

Welcome back to our multiple I.D. guru.
You’ve still not helped out by letting me know what I should be buying.

[dozyduck] 14/6/2020 09:11

If you can't understand just the few things missing I've listed (and don't know what the other one I haven't listed is) you shouldn't invest in a mining share.

[klosters65] 13/6/2020 23:34

Your implausible, There must be easier stocks to pick on to go and quack your trade. ,